GlassScriptPhysician profile
Walter W Rucker
NPI 1386644094
$1,260.08
in general payments reported to CMS, 2019-2025
23 companies · $31.48 in 2025
The $31.48 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $469 · 2021: $463 · 2022: $77.14 · 2023: $82.78 · 2024: $36.13 · 2025: $31.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $188.74 | 2020-2021 | |
| Pfizer INC. | $170.86 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $109.59 | 2020-2023 | Farxiga |
| Novo Nordisk INC | $105.35 | 2020-2021 | |
| Merz North America, INC. | $100.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.78 | 2020-2021 | |
| Abbvie INC. | $68.32 | 2021-2022 | |
| Halozyme INC | $46.31 | 2023 | |
| Sanofi-Aventis U.S. LLC | $44.63 | 2020-2021 | |
| Antares Pharma, INC. | $44.03 | 2022-2024 | Xyosted |
| Amgen INC. | $36.93 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.54 | 2020-2021 | |
| Clarus Therapeutics INC. | $36.47 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.49 | 2020-2021 | |
| Allergan, INC. | $24.58 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $20.24 | 2021 | |
| Inspire Medical Systems, INC. | $17.28 | 2025 | Inspire |
| Scilex Pharmaceuticals INC. | $17.15 | 2020 | |
| Exact Sciences Corporation | $16.87 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $14.20 | 2025 | Venaseal |
| Teva Pharmaceuticals USA, INC. | $14.00 | 2021 | |
| Dexcom, INC. | $12.72 | 2021 | |
| Esperion Therapeutics, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Rucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.